In the present study, the precise incidence of IGF2 LOI in lung carcinomas was examined using PCR-RFLP in combination with DNA sequencing of samples obtained by a laser capture microdissection (LCM) method, as reported previously (16). This evidence concerns the gene IGF2 and lung carcinoma.